sellaslifesciences.com (SLS): Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi

SELLAS Life Sciences Group Inc. (SLS) - korporativ logo

Saraton terapiyasi bo'yicha ixtisoslashgan SELLAS Life Sciences (SLS) kompaniyasining ushbu kunlik narxlar grafigi geosiyosat ta'sirini aks ettiradi, bunda dori-darmonlarga bo'lgan barqaror talab logistika uzilishlari xavfi va patent nizolari bilan to'qnashmoqda. Rahbariyat hozirda spekulyativ qo'llab-quvvatlashga tayangan holda, immuno-onkologiya ishlanmalari uchun ma'lumotlar operatsiyalarini optimallashtirmoqda. Moliyaviy ko'rsatkich 0.00 darajasida turibdi, biznes barqarorligi esa sinov natijalariga bog'liq, chunki kompaniya hali daromad keltirmagan.

SELLAS Life Sciences Group, Inc. (SLS): Uzoq muddatli qarzning kapitalga nisbati 04.07.2022dan 28.10.2026gacha

SLS (SELLAS Life Sciences Group, Inc.): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi SELLAS Life Sciences Group Inc.|SLS - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi SELLAS Life Sciences Group|SLS - Korxona qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun buxgalteriya qiymati SELLAS Life Sciences|SLS - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga koeffitsiyenti sellaslifesciences.com|SLS - Kompaniyaning jami aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Barcha qarzlarning o‘z mablag‘lariga nisbati SELLAS Life Sciences|SLS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati SELLAS Life Sciences Group Inc.|SLS - Kompaniyaning jamlangan qarzlari|Qarzning balans qiymatiga nisbati SELLAS Life Sciences Group
Kompaniyaning umumiy tahlili:SLS sellaslifesciences.com
SELLAS Life Sciences brend mahsuloti

Ushbu koeffitsient bir yildan ortiq muddatli majburiyatlarni kapital bilan taqqoslaydi, bu esa uzoq muddatli moliyaviy barqarorlikni va qarz kapitaliga bog'liqlik darajasini baholash imkonini beradi. Uzoq muddatli qarzning kapitalga nisbati tendentsiyasidagi 0.00 ning joriy qiymati SELLAS Life Sciences (SLS) kompaniyasining peptid vaksinalari uchun qimmatbaho klinik sinovlarni haddan tashqari kredit bosimisiz moliyalashtirish qobiliyatini aks ettiradi.

Muhim raqobatchilar

Uzoq muddatli qarzning kapitalga nisbati ONC|Uzoq muddatli qarzning o'z kapitaliga nisbati Halozyme Inc. HALO|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Revolution Medicines Corp (RVMD)|Ascentage Pharma Group - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati cgoncology.com CGON|URGN (UroGen Pharma) - Uzoq muddatli qarzning kapitalga nisbati|BCAX: Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Personalis Corp PSNL|Uzoq muddatli qarzning kapitalga koeffitsiyenti Erasca Oncology|DCTH - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ymabs.com|Uzoq muddatli qarzning kapitalga nisbati AURA (Aura Biosciences)|Uzoq muddatli qarzning o'z kapitaliga nisbati candeltx.com CADL|Uzoq muddatli qarzning o'z kapitaliga nisbati ARAY (Accuray Inc.)|Actuate Therapeutics Inc - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Citius Oncology, Inc. (CTOR)|HURA - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati TARA|FATE (Fate Therapeutics Inc) - Uzoq muddatli majburiyatlarning kapitalga nisbati|WHWK: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati TScan|Champions Oncology - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati XBIT (xbiotech.com)|Uzoq muddatli qarzning o'z kapitaliga nisbati CEL-SCI CVM|OS Therapies Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|RADX - Uzoq muddatli qarzning o'z kapitaliga nisbati|ARTV - Uzoq muddatli qarzning o'z kapitaliga nisbati|ANL: Uzoq muddatli qarzning kapitalga nisbati|VERU (verupharma.com) - Uzoq muddatli qarzning kapitalga nisbati|TPST: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Xilio (XLO)|Renovaro Inc. (RENB) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti MURA (muraloncology.com)|Uzoq muddatli qarzning o'z kapitaliga nisbati Kairos Pharma KAPA|Uzoq muddatli qarzning o'z kapitaliga nisbati OnKure Therapeutics, Inc. OKUR|Uzoq muddatli qarzning kapitalga nisbati GDTC (CytoMed)|CRIS - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati apollomicsinc.com (APLM)|Tharimmune Corporation (THAR) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ADVB (Advanced Biomed Inc.)|Uzoq muddatli majburiyatlarning kapitalga nisbati genprex.com (GNPX)|Calidi Biotherapeutics (CLDI) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti SBFM (Sunshine Biopharma Inc.)|Uzoq muddatli qarzning o'z kapitaliga nisbati XBIO|Uzoq muddatli qarzdorlikning kapitalga nisbati Salarius Pharma SLRX|PPBT: Uzoq muddatli qarzning kapitalga nisbati|AONC - Uzoq muddatli qarzning o'z kapitaliga nisbati|BeiGene - Uzoq muddatli qarzning kapitalga nisbati|Checkpoint Therapeutics Inc. (CKPT) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ELEV (Elevation Oncology, Inc.)|Uzoq muddatli majburiyatlarning kapitalga nisbati ICAD|Uzoq muddatli qarzning o'z kapitaliga nisbati Ikena Oncology, Inc. IKNA|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi notablelabs.com (NTBL)|Viracta Therapeutics, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati MorphoSys Inc MOR|NAYA (NAYA Bio) - Uzoq muddatli qarzning kapitalga nisbati|AAPGV: Uzoq muddatli majburiyatlarning kapitalga nisbati